カテゴリ： MarketLine, オーストラリア, 企業調査

Sigma Pharmaceuticals Limited：戦略・SWOT・企業財務分析

◆英語タイトル：Sigma Pharmaceuticals Limited - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA8015434
◆発行会社（調査会社）：MarketLine
◆発行日：2017年9月30日
◆ページ数：39
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：オーストラリア
◆産業分野：小売
◆販売価格オプション（消費税別）
Single UserUSD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Sigma Pharmaceuticals Limited – Strategy, SWOT and Corporate Finance Report
Summary

Sigma Pharmaceuticals Limited – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Sigma Pharmaceuticals (Sigma or ‘the company’) is a wholesaler and distributor of pharmaceutical products. The company operates a pharmacy-led network in Australia, with over 1,200 branded and independent pharmacies. It is headquartered in Rowville, Victoria.

Scope

- Detailed information on Sigma Pharmaceuticals Limited required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Sigma Pharmaceuticals Limited in the form of a SWOT analysis
- An in-depth view of the business model of Sigma Pharmaceuticals Limited including a breakdown and examination of key business segments
- Intelligence on Sigma Pharmaceuticals Limited’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Sigma Pharmaceuticals Limited, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Sigma Pharmaceuticals Limited and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Sigma Pharmaceuticals Limited as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Sigma Pharmaceuticals Limited’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Sigma Pharmaceuticals Limited: Company Overview
Sigma Pharmaceuticals Limited: Overview and Key Facts
Sigma Pharmaceuticals Limited: Overview
Sigma Pharmaceuticals Limited: Key Facts
Sigma Pharmaceuticals Limited: Key Employees
Sigma Pharmaceuticals Limited: Key Employee Biographies
Sigma Pharmaceuticals Limited: Major Products and Services
Sigma Pharmaceuticals Limited: Company History
Sigma Pharmaceuticals Limited: Management Statement
Sigma Pharmaceuticals Limited: Locations and Subsidiaries
Sigma Pharmaceuticals Limited: Key Competitors
Sigma Pharmaceuticals Limited: Company Analysis
Sigma Pharmaceuticals Limited: Business Description
Sigma Pharmaceuticals Limited: SWOT Analysis
Sigma Pharmaceuticals Limited: SWOT Overview
Sigma Pharmaceuticals Limited: Strengths
Sigma Pharmaceuticals Limited: Weaknesses
Sigma Pharmaceuticals Limited: Opportunities
Sigma Pharmaceuticals Limited: Threats
Sigma Pharmaceuticals Limited: Corporate Financial Deals Activity
Sigma Pharmaceuticals Limited: Financial Deals Overview
Sigma Pharmaceuticals Limited: Targets and Partners
Sigma Pharmaceuticals Limited: Top Deals 2013 – 2017YTD*
Sigma Pharmaceuticals Limited: Mergers and Acquisitions
Sigma Pharmaceuticals Limited: Recent Developments
Sigma Pharmaceuticals Limited: News and Events Summary
Sigma Pharmaceuticals Limited: Contracts
Sigma Pharmaceuticals Limited: Corporate Governance
Sigma Pharmaceuticals Limited: Financial Deals
Sigma Pharmaceuticals Limited: Financial Performance
Sigma Pharmaceuticals Limited: Strategy and Operations
Appendix
Contact Us
Methodology
Definitions
About MarketLine

List of Tables
Table 1: Sigma Pharmaceuticals Limited: Key Facts
Table 2: Sigma Pharmaceuticals Limited: Key Employees
Table 3: Sigma Pharmaceuticals Limited: Locations and Subsidiaries
Table 4: Sigma Pharmaceuticals Limited: Key Competitors
Table 5: Sigma Pharmaceuticals Limited: Deal Activity by Deal Type - Volume (2013 - YTD*2017)
Table 6: Sigma Pharmaceuticals Limited: M&A Average Deal Size - Value (US$m)
Table 7: Sigma Pharmaceuticals Limited: Targets and Partners
Table 8: Sigma Pharmaceuticals Limited: Top Deals 2013 - 2017YTD*
Table 9: Sigma Pharmaceuticals Limited: M&A Volume and Value Trend (2013 - YTD*2017)
Table 10: Sigma Pharmaceuticals Limited: M&A Activity by Geography (2013 - YTD*2017)
Table 11: Sigma Pharmaceuticals Limited: News and Events Summary
Table 12: Sigma Pharmaceuticals Limited: Contracts
Table 13: Sigma Pharmaceuticals Limited: Corporate Governance
Table 14: Sigma Pharmaceuticals Limited: Financial Deals
Table 15: Sigma Pharmaceuticals Limited: Financial Performance
Table 16: Sigma Pharmaceuticals Limited: Strategy and Operations

★海外企業調査レポート[Sigma Pharmaceuticals Limited：戦略・SWOT・企業財務分析]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • The British United Provident Association Limited ：企業の戦略・SWOT・財務情報
    The British United Provident Association Limited - Strategy, SWOT and Corporate Finance Report Summary The British United Provident Association Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, …
  • OncoSec Medical Inc (ONCS)：企業の財務・戦略的SWOT分析
    Summary OncoSec Medical Inc (OncoSec) is a biotechnology company. The company offers services to stimulate body’s immune system and attack cancer. Its lead candidate, ImmunoPulse IL-12, consists of a plasmid construct encoding the proinflammatory cytokine, IL-12, which is delivered into the tumor th …
  • Odfjell SE (ODF)：石油・ガス：M&Aディール及び事業提携情報
    Summary Odfjell SE (Odfjell) is a shipping company that provides transportation and carrier services for various minerals and oils. The company transports organic and inorganic chemicals, petroleum products, lubricating oils, edible oils, acids, animal fats and portable alcohols. Odfjell owns and op …
  • Bunge Ltd (BG)：企業の財務・戦略的SWOT分析
    Bunge Ltd (BG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Georgia Power Co：企業の発電所・SWOT分析2018
    Georgia Power Co - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (e …
  • Jyske Bank A/S：企業の戦略・SWOT・財務情報
    Jyske Bank A/S - Strategy, SWOT and Corporate Finance Report Summary Jyske Bank A/S - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Gujarat State Electricity Corporation Ltd：企業の戦略的SWOT分析
    Gujarat State Electricity Corporation Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • Religare Enterprises Limited：企業のM&A・事業提携・投資動向
    Religare Enterprises Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Religare Enterprises Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and a …
  • Destination Maternity Corporation (DEST)：企業の財務・戦略的SWOT分析
    Destination Maternity Corporation (DEST) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • GNI Group Ltd (2160)：企業の財務・戦略的SWOT分析
    Summary GNI Group Ltd (GNI) is a healthcare service provider that researches, develops, manufactures and markets pharmaceutical drugs. The company’s business operations consist of drug discovery activities such as drug discovery research, drug discovery infrastructure, fundamental drug discovery and …
  • Houston American Energy Corp Oil & Gas Exploration and Production Operations and Cost Analysis – Q3, 2017
    Houston American Energy Corp Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2017 Summary Houston American Energy Corp (Houston American Energy) is an oil and gas company that provides exploration and development services. The company concentrates on development, exploration, …
  • Novo Nordisk AS (NOVO B)-製薬・医療分野：企業M&A・提携分析
    Summary Novo Nordisk A/S (Novo Nordisk), a subsidiary of Novo A/S discovers, develops and manufactures innovative biological medicines. It focuses at developing drugs for treating diabetes and other serious chronic conditions including hemophilia, growth disorders and obesity. The company’s product …
  • bioMerieux SA (BIM)：医療機器：M&Aディール及び事業提携情報
    Summary bioMerieux SA (bioMerieux), a subsidiary of Institut Merieux SA, develops, manufactures and markets in vitro diagnostic solutions for private and hospital laboratories. The company offers diagnostic solutions such as systems, reagents and software. Its products are used to diagnose infectiou …
  • Volkswagen Financial Services AG：戦略・SWOT・企業財務分析
    Volkswagen Financial Services AG - Strategy, SWOT and Corporate Finance Report Summary Volkswagen Financial Services AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • I.Ceram SA (ALICR)：医療機器：M&Aディール及び事業提携情報
    Summary I.Ceram SA (I.Ceram) is a medical equipment and device company that designs, manufactures, and markets joint implants for neurosurgery and other surgical procedures. The company’s products include bone fillers, alumina bio-ceramic implants, trepan caps, cervical plates and blocks for cervica …
  • Driver and Vehicle Standards Agency：企業の戦略的SWOT分析
    Driver and Vehicle Standards Agency - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Fukuoka Financial Group Inc：企業の戦略・SWOT・財務情報
    Fukuoka Financial Group Inc - Strategy, SWOT and Corporate Finance Report Summary Fukuoka Financial Group Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Enterprise Diversified Inc (SYTE)：企業の財務・戦略的SWOT分析
    Summary Enterprise Diversified Inc (Enterprise Diversified), formerly Sitestar Corp, is a technology company that offers asset management, home services, internet, and real estate programs. The company offers consumer and business-grade internet access, wholesale managed modem services for downstrea …
  • Blueberry Therapeutics Ltd-製薬・医療分野：企業M&A・提携分析
    Summary Blueberry Therapeutics Ltd (Blueberry Therapeutics) is a healthcare products provider that develops therapeutic products. The company develops novel therapies to treat onychomycosis. Its pipeline product portfolio includes BB2603-NCE, developed to treat onychomycosis and associated tinea ped …
  • Memphasys Ltd (MEM)：医療機器：M&Aディール及び事業提携情報
    Summary Memphasys Ltd (Memphasys), formerly Nusep Holdings Ltd, is a bio-separations company that develops and commercializes membrane technology solutions. The company develops felix, a non-DNA damaging lab instrument for sperm separation that separates sperm from semen sample using electrophoresis …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆